Premium
Nightly Home Hemodialysis: Fifteen Months of Experience in Lynchburg, Virginia
Author(s) -
Lockridge Robert S.,
Albert Jeanette,
Anderson Helen,
Barger Terry,
Coffey Lisa,
Craft Viola,
Jennings Floyd M.,
McPhatter Lesley,
Spencer Maureen,
Swafford Angela
Publication year - 1999
Publication title -
home hemodialysis international
Language(s) - English
Resource type - Journals
eISSN - 1542-4758
pISSN - 1480-0225
DOI - 10.1111/hdi.1999.3.1.23
Subject(s) - hemodialysis , medicine , dialysis , nephrology , dialysis adequacy , home hemodialysis , peritoneal dialysis , end stage renal disease , dose , surgery
What constitutes adequate dialysis has been debated in the nephrology literature over the past eight years. The mortality rate of patients on dialysis in the United States is about 20% per year. We believed that short and infrequent dialysis sessions contributed to poor outcomes. To improve the results, Lynchburg Nephrology started the nightly home hemodialysis (NHHD) program in September 1997. Ten patients were trained in the first 15 months of the program. Patients dialyzed 7 – 9 hours, 6 nights/week, using the Fresenius 2008H machine. A standard dialysis solution with 2.0 mEq/L potassium, calcium concentration of 3.0 – 3.5 mEq/L was used. Dialysis solution flow rates were 200 – 300 mL/min. Serum phosphate levels were maintained above 2.5 mg/dL by adding 0 – 45 mL Fleet's Phosphosoda to the bicarbonate bath. Patients had marked improvement in quality of life as measured with the SF‐36. Blood pressure was better controlled with fewer medications. All phosphate binders were eliminated. Caloric intake and protein intake increased to normal levels as measured by three‐day dietary histories pre‐NHHD, and at 3, 6, and 12 months on NHHD. Epoetin alfa dosages were reduced by about 50%. Nightly home hemodialysis should be considered as a valuable modality option for end‐stage renal disease patients; it is potentially superior to conventional thrice‐weekly hemodialysis.